scispace - formally typeset
G

Guo-Qiang Chen

Researcher at Tsinghua University

Publications -  661
Citations -  52601

Guo-Qiang Chen is an academic researcher from Tsinghua University. The author has contributed to research in topics: Polyhydroxyalkanoates & Acute promyelocytic leukemia. The author has an hindex of 94, co-authored 621 publications receiving 45953 citations. Previous affiliations of Guo-Qiang Chen include Qingdao University & Icahn School of Medicine at Mount Sinai.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy

Daniel J. Klionsky, +1287 more
- 01 Apr 2012 - 
TL;DR: These guidelines are presented for the selection and interpretation of methods for use by investigators who aim to examine macroautophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus.

Qing Ling Feng, +5 more
- 15 Dec 2000 - 
TL;DR: The existence of elements of silver and sulfur in the electron-dense granules and cytoplasm detected by X-ray microanalysis suggested the antibacterial mechanism of silver: DNA lost its replication ability and the protein became inactivated after Ag(+) treatment.
Journal ArticleDOI

Use of Arsenic Trioxide (As2O3 ) in the Treatment of Acute Promyelocytic Leukemia (APL): II. Clinical Efficacy and Pharmacokinetics in Relapsed Patients

Zhi-Xiang Shen, +19 more
- 01 May 1997 - 
TL;DR: As2O3 treatment is an effective and relatively safe drug in APL patients refractory to ATRA and conventional chemotherapy, and Pharmacokinetic studies showed that after a peak level of 5.54 micromol/L, plasma arsenic was rapidly eliminated, and the continuous administration of As2O2 did not alter its pharmacokinetic behaviors.
Journal ArticleDOI

The application of polyhydroxyalkanoates as tissue engineering materials.

Guo-Qiang Chen, +1 more
- 01 Nov 2005 - 
TL;DR: The PHA prospective will look very bright in the near future, according to this paper's review of what have been achieved in the PHA tissue engineering area and the changing PHA compositions.